Standard BioTools
LAB
LAB
65 hedge funds and large institutions have $42.5M invested in Standard BioTools in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 28 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
54% less call options, than puts
Call options by funds: $44K | Put options by funds: $96K
84% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 25
Holders
65
Holding in Top 10
–
Calls
$44K
Puts
$96K
Top Buyers
| 1 | +$670K | |
| 2 | +$438K | |
| 3 | +$436K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$178K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$153K |
Top Sellers
| 1 | -$3.18M | |
| 2 | -$1.82M | |
| 3 | -$656K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$626K |
| 5 |
Millennium Management
New York
|
-$478K |